Dr. Selvia Hanna | Clinical Pharmacy | Best Researcher Award
Senior Clinical Pharmacist | Beni-Suef University Hospital | Egypt
👩🔬 Short Bio:
Selvia Maher Farag Hanna is a dedicated Senior Clinical Pharmacist and Member of the Clinical Research Center at Beni-Suef University Hospital, specializing in Cardiology. With 12 years of experience, she excels in medication therapy management and improving patient outcomes through interdisciplinary collaboration.
Profile:
📚 Education:
Selvia completed her Doctor of Philosophy in Pharmaceutical Sciences (Clinical Pharmacy) at Beni-Suef University in July 2024. She holds a Master’s degree in Pharmaceutical Sciences (Clinical Pharmacy) and a Bachelor’s degree in Pharmaceutical Sciences, both from Beni-Suef University.
💼 Experience:
Since July 2012, Selvia has served as a Clinical Pharmacist at Beni-Suef University Hospital, focusing on medication management in the Cardiology care unit. Previously, she worked at El-Masrya Pharmacy, gaining experience in medication counseling and drug utilization review.
🔬 Research Interest:
Selvia’s research interests revolve around Cardiology, specifically hypertension management, drug interactions, and patient-centric care strategies to enhance treatment efficacy and safety.
🏆 Award:
Recipient of the Distinguished Scientist Award for her contributions to Clinical Pharmacy and Cardiology research.
📄 Publications:
- Effect of Amlodipine/Valsartan Versus Nebivolol/Valsartan Fixed Dose Combinations on Peripheral and Central Blood Pressure
Published in High Blood Pressure & Cardiovascular Prevention, November 2018.
View Publication
Cited 11 times. - Effect of Fixed-dose Combination Amlodipine/Valsartan in Comparison to Two Drug Combination Nebivolol/Valsartan on 24-Hour Ambulatory Blood Pressure
Published in Current Hypertension Reviews, May 2023.
View Publication - Target Blood Pressure and Combination Therapy: Focus on Angiotensin Receptor Blockers Combination with Either Calcium Channel Blockers or Beta Blockers
Published in Current Hypertension Reviews, September 2022. - Safety and efficacy of candesartan versus valsartan combined with amlodipine on peripheral and central blood pressure
Published in Hipertension y Riesgo Vascular, January–March 2024.